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Mutations in human TBX5, a member of the T-box transcription factor gene family, cause congenital cardiac septation
efects and isomerism in autosomal dominant Holt–Oram syndrome. To determine the cellular function of TBX5 in
ardiogenesis, we overexpressed wild-type and mutant human TBX5 isoforms in vitro and in vivo. TBX5 inhibited cell
roliferation of D17 canine osteosarcoma cells and MEQC quail cardiomyocyte-like cells in vitro. Mutagenesis of the 5* end
f the T-box but not the 3* end of the T-box abolished this effect. Overexpression of TBX5 in embryonic chick hearts showed
hat TBX5 inhibits myocardial growth and trabeculation. TBX5 effects in vivo were abolished by Gly80Arg missense
utation of the 5* end of the T-box. PCNA analysis in transgenic chick hearts revealed that TBX5 overexpression does
uppress embryonic cardiomyocyte proliferation in vivo. Inhibitory effects of TBX5 on cardiomyocyte proliferation include
a noncell autonomous process in vitro and in vivo. TBX5 inhibited proliferation of both nontransgenic cells cocultured with
transgenic cells in vitro and nontransgenic cardiomyocytes in transgenic chick hearts with mosaic expression of TBX5 in
vivo. Immunohistochemical studies of human embryonic tissues, including hearts, also demonstrated that TBX5
expression is inversely related to cellular proliferation. We propose that TBX5 can act as a cellular arrest signal during
vertebrate cardiogenesis and thereby participate in modulation of cardiac growth and development. © 2001 Academic PressINTRODUCTION
TBX5, a T-box transcription factor (Chapman et al.,
996), plays a critical role in vertebrate cardiac morphogen-
sis. Mutations in human TBX5 cause Holt–Oram syn-
drome, an autosomal dominant disorder characterized by
cardiac malformation, including defects in septation and
isomerism, and upper limb deformity (Basson et al., 1997,
1999; Li et al., 1997). Although alterations in human TBX5
gene dose, either haploinsufficiency or TBX5 overexpres-
sion via gene duplication (Melnyk et al., 1981; McCor-
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2 To whom correspondence should be addressed at Molecular
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eill Medical College of Cornell University, 525 E. 68th Street,
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ed.cornell.edu.
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All rights of reproduction in any form reserved.quodale et al., 1986; Dixon et al., 1993; Hatcher and Basson,
2000), severely perturb both heart and limb development,
missense mutations in TBX5 affect the heart and limb to
varying degrees (Basson et al., 1999; Yang et al., 2000).
Modification of either end of the T-box alters DNA binding
in vitro (Kispert and Herrmann, 1993; Herrmann and Kis-
pert, 1994). In humans, missense mutations which disrupt
the 59 end of the T-box have more severe cardiac effects
than missense mutations at the 39 end of the T-box (Basson
et al., 1999; Yang et al., 2000). These missense mutations
map to domains at the 59 and 39 ends of the T-box that have
been predicted by X-ray crystallographic studies to include
binding sites for the major and minor grooves of target
DNA, respectively (Mu¨ller and Herrmann, 1997; Basson et
al., 1999).
Little is known about the specific cellular activities
regulated by TBX5 during cardiogenesis. Others (Rodriguez-
Esteban et al., 1999; Takeuchi et al., 1999) have used data
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178 Hatcher et al.from investigation of overexpression of Tbx5 in the chick
limb to demonstrate that Tbx5 contributes to the establish-
ment of limb identity during embryogenesis. Rodriguez-
Esteban et al. (1999) further hypothesized that chick Tbx5
ight interact with growth factors to modify cell prolifera-
ion during limb outgrowth and specification. A similar role
or Tbx5 has been hypothesized during newt limb regenera-
ion and specification [Simon et al. (1997)]. Horb and
homsen (1999) demonstrated that Tbx5 was essential for
ormal cardiac morphogenesis in Xenopus, and recently,
iberatore et al. (2000) showed that overexpression of TBX5
n the ventricles during mouse cardiogenesis resulted in
bnormal chamber specification and noted that their find-
ngs could be consistent with altered cell proliferation
ithin the myocardium. In the current studies, we now
emonstrate that ectopic overexpression of human TBX5
nhibits cell proliferation in vitro and during chick cardio-
enesis in vivo. This TBX5 activity is no longer evident if
he glycine at position 80 is mutated to arginine. Immuno-
istochemistry reveals that TBX5 localization is inversely
elated to localization of nuclear markers of cell prolifera-
ion during human cardiogenesis. We, therefore, propose that
BX5 acts as a cellular arrest signal during vertebrate cardiac
evelopment.
MATERIALS AND METHODS
Site-Directed Mutagenesis of Human TBX5
The Gly80Arg–TBX5 mutant cDNA was generated by PCR with
he QuikChange Site-Directed Mutagenesis kit (Stratagene) per the
nstructions of the manufacturer. PCR-based mutagenesis of wild-
ype TBX5.3 cDNA in pBSIIKS (2) plasmid (Basson et al., 1997,
999) was performed with two synthetic oligonucleotide primers
59-CATAACCAAGGCTAGAAGGCGGATGTTTC-39 and 59-
GAAACATCCGCCTTCTAGCCTTGGTTATG-39) containing
the G238A transition mutation (mutated bases are underlined in
primer sequences above; Basson et al., 1999). DAsn198FSter–TBX5
as a naturally occurring mutation in the TBX5.2 clone (Basson et
l., 1997). Both mutations were confirmed by automated sequenc-
ng on an ABI 377 sequencer.
Retroviral TBX5 Constructs
The CXIZ retrovirus used in the present study is a replication-
defective variant of the avian spleen necrosis virus (Mikawa, 1995;
Takebayashi-Suzuki et al., 2000). Construction of the viral vectors
and propagation of the recombinant virus have been previously
described (Mikawa et al., 1992b; Mikawa, 1995; Mima et al., 1995;
Takebayashi-Suzuki et al., 2000). A 1935-bp fragment containing
the entire TBX5 coding sequence (exons 2–9) was excised
from wild-type or mutant TBX5.3 or TBX5.2 cDNA in
pBSIIKS (2) plasmid with SacII and StuI. Linker adaptor pairs
(59-GGGAGCGCGCGTAATACGACTCACTATAGAACCGC-39/
59-GGTTCTATAGTGAGTCGTATTACGCGCGCTCCC-39;
59-GAAATCACTCCCAATTAACGCGCGAAT-39/59-CTAGATT-
CGCGCGTTAATTGGGAGTGATTTC-39) were ligated to the 59
and 39 ends of the TBX5 inserts, and inserts were then were sub-
cloned into SmaI and XbaI restriction enzyme sites in the pCXIZ
Copyright © 2001 by Academic Press. All rightplasmid. TBX5 coding sequences were thereby inserted into pCXIZ
between the 59LTR and an internal ribosome entry sequence (IRES)
FIG. 1. Retroviral overexpression of wild-type and mutant TBX5. (a)
Schematic of TBX5 cDNA showing the T-box DNA binding domain.
X-ray crystallographic studies (Mu¨ller and Herrmann, 1997) have
predicted disparate binding sites for target DNA major groove (dark
gray) and for target DNA minor groove (light gray). These sites are
shown relative to the positions of the Gly80Arg missense mutation
(closed arrow), the DASN198FSter truncation mutation (open arrow),
nd the anti-TBX5 antibody recognition epitope (*). (b) RT-PCR
nalysis of D17 cells infected with TBX5-CXIZ viruses demonstrates
ranscription of the TBX5 transgene. A 780-bp portion of TBX5 cDNA
s amplified from D17s infected with wt-TBX5-CXIZ (lane 3),
ly80Arg-TBX5-CXIZ (lane 4), and DAsn198FSter-TBX5-CXIZ (lane
), but not from D17s infected with the CXIZ retrovirus alone (lane 2).
t-PCR experimental controls (lanes 6–10) demonstrate no genomic
NA contamination was present in total cellular RNA isolated from
17s infected with CXIZ retrovirus alone (lane 7), wt-TBX5-CXIZ
lane 8), Gly80Arg-TBX5-CXIZ (lane 9), or DAsn198FSter-0TBX5-
XIZ (lane 10). DNA size marker, fX174/HaeIII, is shown in lanes 1
and 6. (c) Western blot analysis with anti-TBX5 antibody demon-
strates specific synthesis of 58 kDa rhTBX5 protein by D17s infected
with TBX5-CXIZ retroviruses. (1) Recombinant 62 kDa calmodulin
binding protein-TBX5 fusion protein (Hatcher et al., 2000); (2) D17
cells; (3) CXIZ-infected D17s; (4) wt-TBX5-CXIZ infected D17s; (5)
Gly80Arg-TBX5-CXIZ infected D17s; (6) DAsn198FSter-TBX5-CXIZ
nfected D17s. Note that the mutant DAsn198FSter-TBX5 protein is
ot recognized by anti-TBX5 since this mutant isoform is truncated
rior to the antibody recognition site (see a). Shown below the
estern blot analysis of infected D17s for rhTBX5 synthesis are
estern blot analyses of infected D17s for recombinant
b-galactosidase (encoded by CXIZ retroviruses) and for native actin.derived from the 59 untranslated region of the encephalomyocardi-
s of reproduction in any form reserved.
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179TBX5 Inhibits Proliferation during Cardiogenesistis virus genome. Because the IRES is upstream from the bacterial
lacZ gene, both the subcloned TBX5 transgene and the lacZ gene
re expressed from a dicistronic mRNA. Cotranslation of the trans-
ene and b-galactosidase from the dicistronic mRNA in daughter
populations from infected cells has been previously demonstrated
both in tissue culture and in chick embryos (Mikawa et al., 1992b,
Mima et al., 1995). Automated sequencing on an ABI 377 sequencer
of all pCXIZ plasmids confirmed the appropriate TBX5 isoform
sequence. Viruses were propagated and titers assayed per published
protocols (Mikawa et al., 1992b; Takebayashi-Suzuki et al., 2000).
We obtained titers of approximately 106 virions/ml for all CXIZ
viruses in the supernatant of each clone of virus-producing cells.
Cell Proliferation
Over a 48-h period, 2 3 105 D17 canine osteosarcoma cells or
MEQC cells (a myc-transformed avian cardiomyocyte-like cell line,
gift of T. Jaffredo and A. Conrad; Jaffredo et al., 1991) were infected
ith 5 3 104 virions of modified CXIZ virus encoding wild-type or
mutant (Gly80Arg or DAsn198FSter) TBX5 isoforms or unmodified
CXIZ control virus in the presence of 10 mg/ml polybrene. Cells
were then harvested and replated at 5 3 104 cells per 60 mm2 dish.
ells were grown in culture for 1 to 4 days, and at multiple time
oints, culture dishes were fixed with 2% paraformaldehyde and
tained with X-Gal (5-bromo-4-chloro-3-indolyl-b-gal) for b-galac-
osidase activity. The number of b-galactosidase-positive and
-negative cells/16 mm2 was determined by direct visualization via
light microscopy beginning 6 h after plating.
Retroviral Infection of Chick Embryos In Ovo
Media supernatants containing CXIZ viruses encoding
b-galactosidase and TBX5 isoforms or, for control experiments,
b-galactosidase alone were collected and concentrated by ultracen-
trifugation as previously described (Mikawa et al., 1992b). Fertil-
ized chick eggs obtained from an outbred flock were incubated at
37.5°C in a humidified atmosphere until Hamburger–Hamilton
(HH) stages 17–18 (Hamburger and Hamilton, 1951). A 5–10 mm
diameter window was opened in the shell at the blunt end of the
egg and the underlying shell membrane was removed. Ten to 100
viral particles in 1–5 nl solution (DMEM with 7% FBS) containing
100 mg/ml polybrene were pressure-injected into the myocardium
FIG. 2. Immunohistochemical detection of overexpression of wi
17s infected with wt-TBX5-CXIZ (a) or Gly80Arg-TBX5-CXIZ
ranscription factor to the cell nuclei, but not in D17s infected wiof the beating tubular heart in ovo as previously described (Mima et
Copyright © 2001 by Academic Press. All rightl., 1995). Eggs were resealed with parafilm and incubated until
mbryos were sacrificed at E15. Six to 16 embryos were injected
ith each virus. In ovo infection efficiency was determined by
xing the hearts with 2% paraformaldehyde and staining overnight
or b-galactosidase activity with X-Gal. CXIZ-mediated gene ex-
pression has been previously demonstrated (Wei and Mikawa,
2000) to begin within 7–9 h of retroviral microinjection.
Immunohistochemistry of Human
and Chick Tissues
Human cardiac tissue was obtained as waste surgical pathology
material from therapeutic abortions of ten 10–15 gestational week
e and mutant TBX5 in cultured cells. Immunohistochemistry of
r rhTBX5 demonstrates translocation of the recombinant TBX5
e CXIZ retrovirus alone (panel b). (Bar 5 10 mm.)
FIG. 3. Effect of overexpression of wild-type and mutant TBX5
isoforms on D17 proliferation. D17 cells were infected with wt-
TBX5-CXIZ (solid line, n ), CXIZ alone (solid line, F), or mutant
TBX5-CXIZ isoforms (dashed lines), Gly80Arg-TBX5-CXIZ (large
dashes, }) or DAsn198FSter-TBX5-CXIZ (small dashes, ). The
number of infected D17 cells (identified by histochemical staining
for b-galactosidase activity) per 16 mm2 was determined by direct
visualization at daily time points over 4 days. Wt-TBX5 overex-
pression inhibits cell proliferation as does overexpression of
DAsn198FSter-TBX5. However, the Gly80Arg mutation blocksld-typ
(c) foTBX5-mediated inhibition of D17 proliferation.
s of reproduction in any form reserved.
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180 Hatcher et al.embryos with informed consent and approval of the Cornell
Committee on Human Rights on Research (Hatcher et al., 2000).
Embryonic chick cardiac tissues were obtained at E15. Tissues
were paraformaldehyde-fixed and paraffin-embedded, or they were
flash frozen and embedded in tissue freezing medium (Fisher) for
cryosectioning.
Five micron paraffin sections were either pretreated with antigen
retrieval (Biogenex) and incubated with affinity-purified anti-TBX5
(Hatcher et al., 2000) or anti-Ki67 (Dako) or were incubated directly
without pretreatment with anti-b-galactosidase (Biogenesis), or
nti-PCNA (Dako). Bound primary antibody was detected with
econdary antibody conjugated to horseradish peroxidase or alka-
ine phosphatase (LSAB2, Dako). Double immunostaining was
erformed with the Envision Double Staining Kit (Dako) and
ector Red alkaline phosphatase substrate (Vector).
Ten micron frozen sections were air dried and then incubated
ith primary antibodies: anti-atrial myosin heavy chain (AMHC1,
ift of Dr. Robert Gourdie, Medical College of South Carolina;
anders et al., 1984), anti-actin (Sigma), or affinity-purified anti-
BX5. Bound primary antibody was detected with secondary anti-
ody conjugated to horseradish peroxidase (LSAB2, Dako). To
etect apoptotic cells, frozen sections were fixed in paraformalde-
yde and then analyzed with a modified TUNEL assay, the Dead-
nd Colorimetric Apoptosis Detection System (Promega), per the
nstructions of the manufacturer. In brief, sections were permeabil-
zed with proteinase K, incubated with biotinylated nucleotides
nd terminal deoxynucleotidyl transferase, washed in 23 SSC,
uenched with 0.3% hydrogen peroxide, incubated with
treptavidin–horseradish peroxidase, and product visualized with
iaminobenzidine chromogen. Control sections were treated with
Nase after permeabilization.
Immunohistochemistry of Cultured Cells
Cells were fixed in McClean’s fixative (10 mM NaIO4, 750 mM
ysine, 37.5 mM NaPO4, 2% paraformaldehyde) for 30 min on ice
and then permeabilized with 0.2% Triton in PBS for 20 min on ice.
Overnight blocking for nonspecific binding sites was performed at
4°C in 3% bovine serum albumin/PBS. Further immunohisto-
chemical staining was performed with affinity-purified anti-TBX5
and the LSAB2 peroxidase system (Dako) per the instructions of the
manufacturer. The DeadEnd Colorimetric Apoptosis Detection
System (Promega) was used for detection of apoptotic cell death in
cultured cells in the same manner as for detection in tissue
sections except cells were permeabilized with Triton X-100 instead
of proteinase K.
RT-PCR
Total RNA was isolated from cell cultures using the RNeasy
Mini Kit (Qiagen) and DNase-treated. To analyze rhTBX5 mRNA
expression, 500 ng RNA was reverse transcribed and subsequently
amplified by the Access RT-PCR System (Promega) with primers
TBX5ATGF (59-ATGGCCGACGCAGACGAGGGC-39) and TBX5-
AGGR (59-AGGTCTGGTGCTGGAACATT-39). To ensure that
genomic DNA was not contaminating our total RNA sample and,
thus amplified as a product of the PCR reaction, we performed
parallel control rt-PCR experiments in which rt-PCR of total RNA
was performed in the presence of DNA polymerase alone without
reverse transcriptase. Amplified material was purified (Qiaquick,
Qiagen) and a subsequent nested PCR amplification [94°C 3 2 min
Copyright © 2001 by Academic Press. All rightfollowed by (94°C 3 30 s, 58°C 3 30 s, 72°C 3 1 min) 3 35 cycles]
as performed with primers 29exF (59-CGGGCAAAGCTGAGC-
9) and ex9R (59-GCTGGCATACATGCAAGCTTGCCGC-39) to
mplify a 780-bp product. PCR products were analyzed on 2%
garose gels.
SDS–PAGE and Western Blotting
Cultured cells were solubilized in 2% SDS. Lysate corresponding
to 50 mg of total protein was electrophoresed on a 7.5% acrylamide
enaturing gel and transferred to PVDF membrane. Protein expres-
ion was detected by Western blotting with primary antibody: 0.2
mg/ml affinity-purified anti-TBX5, 1 mg/ml anti-b-galactosidase
ICN), or 0.7 mg/ml anti-actin (Sigma). Bound primary antibody was
etected by ECL (Amersham).
RESULTS
In Vitro Analysis of TBX5 Activity
To study TBX5 effects on cell proliferation in vitro,
human TBX5 isoforms were expressed in D17 canine
osteosarcoma cells; canine osteosarcoma cells have pre-
viously been used to model aspects of osteoblast differ-
entiation (Mealy et al., 1998; Shoieb et al., 1998). D17
ells were infected with CXIZ retroviruses (Mikawa et
l., 1992b; Takebayashi-Suzuki et al., 2000) encoding
b-galactosidase and wild-type (wt) or mutant (Gly80Arg
nd DASN198FSter) TBX5 isoforms (Fig. 1a). The
Gly80Arg mutation alters the 59 end of the T-box at a
putative binding domain for target DNA’s major groove
(Herrmann and Kispert, 1994; Mu¨ller and Herrmann,
1997; Basson et al., 1999). In contrast, the DASN198FSter
mutation does not modify this domain but yields a
truncated protein that lacks the 39 end of the T-box
including a putative T-box binding domain for target
DNA’s minor groove (Kispert and Herrmann, 1993; Herr-
mann and Kispert, 1994; Kispert et al., 1995; Mu¨ller and
Herrmann, 1997; Li et al., 1997; Basson et al., 1999).
rt-PCR and Western blot analyses (Hatcher et al., 2000) of
infected D17s (Figs. 1b and 1c) confirmed expression of
rhTBX5, and immunohistochemistry demonstrated local-
ization to the cell nucleus (Fig. 2).
Quantification of cell proliferation (Fig. 3) revealed that
wt-TBX5-CXIZ-infected D17s proliferated more slowly
than D17s infected with CXIZ alone. Similar inhibition
of D17 proliferation results from infection with
DASN198FSter-TBX5-CXIZ but not Gly80Arg-TBX5-
CXIZ. Changes in cell number were not a result of altered
cell survival, since no induction of apoptosis was seen in
the presence or absence of any TBX5 isoform.
To determine if TBX5-mediated inhibition of cell prolif-
eration was cell autonomous, we assessed the proliferation
rates of uninfected D17 cells cocultured with D17s infected
with TBX5 retroviruses. We observed that after 4 days of
culture, uninfected D17s cocultured with wt-TBX5-CXIZ-
D17s exhibited a 32% reduction (P , 0.01) in cell number
s of reproduction in any form reserved.
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181TBX5 Inhibits Proliferation during Cardiogenesiscompared with D17s cocultured with control CXIZ-D17s.
D17s cocultured with Gly80Arg-TBX5-CXIZ-D17s exhib-
ited normal proliferation while those cocultured with
DASN198FSter-TBX5-CXIZ-D17s exhibited a 25% reduc-
tion (P , 0.01) in cell number compared with controls.
Thus, we concluded that TBX5 inhibition of D17 prolifera-
tion was not cell autonomous.
Because humans heterozygous for the Gly80Arg TBX5
mutation exhibit severe cardiac manifestations of Holt–
Oram syndrome, and this mutation abrogates TBX5 abil-
ity to inhibit D17 cell proliferation, we hypothesized that
TBX5 might inhibit cardiomyocyte proliferation. As an
initial in vitro test of this hypothesis, we assayed the
effects of TBX5 overexpression on MEQC proliferation
just as we had with D17 cells. Qualitatively similar
effects were seen by TBX5 isoform overexpression on
MEQCs as on D17s. By 3 days of culture, MEQCs infected
with wt-TBX5-CXIZ or DASN198FSter-TBX5-CXIZ ex-
hibited 58 and 52% reductions in cell number, respec-
tively, compared with CXIZ infected MEQCs (P , 0.01).
o significant effect on MEQC proliferation resulted
rom infection with Gly80Arg-TBX5-CXIZ. TBX5 in-
ibition of MEQC proliferation, similar to its inhibition
f D17 proliferation, was not cell autonomous. Unin-
ected MEQCs cocultured for 3 days with wt-TBX5-CXIZ
r DASN198FSter-TBX5-CXIZ exhibited 30 and 57%
eductions in cell number, respectively, compared
ith those cocultured with CXIZ-infected MEQCs (P ,
.01).
In Vivo Analysis of TBX5 Activity during Chick
Cardiogenesis
Because transformed cell lines have a limited capacity to
model physiologic cardiomyocyte behavior in vivo, we
lected to directly explore consequences of TBX5 overex-
ression in vivo in embryonic chick hearts. TBX5-CXIZ
as microinjected into HH stage 17–18 chick heart myo-
ardium (Hamburger and Hamilton, 1951; Mikawa et al.,
992b; Mima et al., 1995; Takebayashi-Suzuki et al., 2000).
FIG. 4. Retroviral-mediated overexpression of wild-type and muta
chicks were microinjected with CXIZ retrovirus with or without va
fixed, stained for b-galactosidase activity, and processed for light mi
of hearts infected with (a,e,i,m) CXIZ alone, (b,f,j,n) wt-TBX5-CX
CXIZ. (a–d) Analysis of whole mounts reveals mosaic expressi
representative transverse sections through the left ventricular free
size (see Table 1) in hearts infected with wt-TBX5 and DAsn198FS
Representative microscopic images of these genetically manipulate
ventricular free wall; and (m–p) the right atrium are shown. These
hearts which overexpress wt-TBX5 (f,j) and DAsn198FSter-TBX5 (
control CXIZ-infected hearts (e,i) and Gly80Arg-TBX5 overexpressi
observed in hearts which overexpress wt-TBX5 (n) and DAsn198
Gly80Arg-TBX5 overexpressing hearts (p). [Bar (e) for microscopic imag
Copyright © 2001 by Academic Press. All rightWhole-mount staining for b-galactosidase activity at E15
confirmed mosaic expression of TBX5/b-galactosidase
mRNA throughout all cardiac chambers (Figs. 4a–4d), and
anti-TBX5 immunohistochemistry confirmed rhTBX5
isoform expression by cardiomyocytes exhibiting b-galac-
tosidase activity (Fig. 5). Although a minority of cardiomy-
ocytes expressed rhTBX5 isoforms, significant effects on
overall cardiac morphology and size were noted (Figs. 4a–
4d). Chick hearts infected with wt-TBX5 retrovirus were
approximately 15% smaller than controls (Table 1). Over-
expression of DASN198FSter-TBX5, which, like wt-TBX5,
inhibited proliferation in vitro, resulted in similarly small
hearts, while overexpression of Gly80Arg-TBX5, an isoform
that did not alter proliferation in vitro, had no effect on
eart size. TUNEL assay demonstrated no evidence of
ncreased apoptosis in any of the TBX5 isoform transgenic
hick hearts.
Microscopic analyses suggested further consequences of
BX5 overexpression (Figs. 4e–4p). Overexpression of both
t-TBX5 and DASN198FSter-TBX5 produced marked de-
reases in left and right ventricular trabeculation compared
ith controls, while overexpression of Gly80Arg-TBX5 did
ot modify trabeculation (Figs. 4e–4l). Patchy thinning of
oth atrial walls was also noted in hearts infected with
t-TBX5-CXIZ and DASN198FSter-TBX5-CXIZ, but not
ith Gly80Arg-TBX5-CXIZ (Figs. 4m–4p). Just as the
ly80Arg mutation blocks TBX5-mediated inhibition of
hick cardiac trabeculation, humans who are heterozygous
or Gly80Arg-TBX5 exhibit abnormal isomerism with
arkedly increased ventricular trabeculation even in the
bsence of septation defects (Basson et al., 1994, 1999; Gall
t al., 1966). Morphologic changes of the ventricles as a
onsequence of TBX5 overexpression in the developing
hick heart were not associated with abnormal chamber
pecification. Immunohistochemical studies (Fig. 6) to lo-
alize atrial myosin heavy chain demonstrated that its
xpression remained restricted to the atria in E15 chick
earts and absent from the ventricles in hearts infected
ith wt-TBX5-CXIZ.
Ventricular trabeculation during cardiogenesis has been
BX5 in embryonic chick hearts. Tubular hearts of HH stage 17–18
TBX5 isoforms. Chicks were sacrificed at E15, and the hearts were
opy. Whole mounts (a–d) and histological sections (e–p) are shown
c,g,k,o) DAsn198FSter-TBX5-CXIZ, and (d,h,l,p) Gly80Arg-TBX5-
f the transgene; insert images show transmural mosaicism in
Gross anatomical analyses also demonstrate a decrease in overall
BX5 retroviruses. [Bar (a) for whole-mount images 5 1 mm.] (e–p)
rts from (e–h) the mid-left ventricular free wall, (i–l) the mid-right
ies demonstrate failed or rudimentary ventricular trabeculation in
ompared with normal ventricular trabeculation (large arrows) in
earts (h,l). Patchy thinning (small arrows) of the atrial walls is also
-TBX5 (o) compared with control CXIZ infected hearts (m) andnt T
rious
crosc
IZ, (
on o
wall.
ter-T
d hea
stud
g,k) c
ng h
FSteres 5 250 mm.]
s of reproduction in any form reserved.
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183TBX5 Inhibits Proliferation during Cardiogenesisassociated with cardiomyocyte proliferation (Sedmera et
al., 2000). Ribozyme antagonism of the mitogen neu-
regulin-1 (Zhao and Lemke, 1998) and overexpression of the
growth arrest protein Gax (Fisher et al., 1997) both decrease
cardiomyocyte proliferation with consequent failure of tra-
beculation. Given our observations that TBX5 inhibits
FIG. 5. Immunohistochemical detection of retroviral-mediated
rhTBX5 overexpression in ovo. Embryonic chick hearts infected
with CXIZ retrovirus alone (a), wt-TBX5-CXIZ (b), or Gly80Arg-
TBX5-CXIZ were prepared for histology at E15 as in Fig. 3. Five
micron sections were immunostained for b-galactosidase activity
blue) and anti-TBX5 (brown). These studies confirmed nuclear
xpression of rhTBX5 in cardiomyocytes infected by retrovirus and
hus exhibiting cytoplasmic b-galactosidase activity.MEQC proliferation in vitro and that TBX5 overexpression
Copyright © 2001 by Academic Press. All rightin vivo yields impaired heart growth with decreased ven-
tricular trabeculation, we hypothesized that TBX5 might
alter myocardial cell proliferation in vivo. To evaluate
chick cardiomyocyte proliferation in vivo, we immunohis-
tochemically assessed cardiomyocyte synthesis of prolifer-
ating cell nuclear antigen (PCNA). The fraction of PCNA-
positive cells (Fig. 7) was reduced by 40 and 50% among
cardiomyocytes that overexpressed wt-TBX5 and
DASN198FSter-TBX5, respectively, compared with cardio-
myocytes infected with CXIZ alone. Infection with
Gly80Arg-TBX5 had no significant effect on PCNA positiv-
ity. Remarkably, in all genetically manipulated chick
hearts, cardiomyocytes in trabeculae without evidence of
retroviral infection exhibited the same degree of PCNA
positivity as those in adjacent trabeculae which did express
rhTBX5 isoforms (Fig. 7). Thus, the capacity of TBX5 to
inhibit cell proliferation in vivo as well as in vitro is not cell
autonomous, and our findings suggest that TBX5 transcrip-
tional regulation of other genes contributes to paracrine
signaling among cardiac cells during development.
TBX5 Expression during Human Organogenesis
The ability of TBX5 to inhibit cell proliferation in vitro
and during chick cardiogenesis prompted us to analyze the
relationship between cell proliferation and TBX5 expres-
sion during human organogenesis. TBX5 expression pat-
terns during human embryogenesis were compared with
expression patterns of two markers of cell proliferation,
PCNA and Ki-67, in 10 human embryos of 10–15 weeks of
gestation. Immunohistochemical analyses of embryonic
human heart, limb, and eye (Fig. 8) revealed that regions of
developing tissue which showed significant cellular prolif-
eration, marked by either PCNA (not shown) or Ki-67
staining, exhibited minimal staining for TBX5 and vice
versa. TBX5 expression in the heart, as previously described
(Chapman et al., 1996; Li et al., 1997; Bruneau et al., 1999;
Hatcher et al., 2000), was highest in the atria and lowest in
the ventricular myocardium (Figs. 8a and 8c), while cell
proliferation was highest in the ventricular myocardium
(Fig. 8b). In the embryonic thumb, TBX5 expression was
high in developing bone of the distal phalanx (Fig. 8e) and
low in musculature surrounding the distal phalanx (Fig. 8g),
while cell proliferation showed the opposite pattern (Figs. 8f
and 8h). Striking contrast between TBX5 expression and
cell proliferation was also observed in the sensory retina of
the developing eye where TBX5 was present only in the
inner cell layer, not in the outer cell layer (Fig. 8i), to which
we, like others (Gao and Hollyfield, 1995), have observed
that cell proliferation is restricted (Fig. 8j). Thus, we ob-
served a reciprocal relationship between TBX5 expression
and cell proliferation not only in experimental tissue cul-
ture and animal models but also in retrospective immuno-
histochemical analyses of human organogenesis.
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In this report, we have demonstrated that TBX5 has a
profound inhibitory effect on cell proliferation in vitro.
Mosaic overexpression of TBX5 in vivo during chick cardio-
genesis resulted in impaired cardiac morphogenesis which
was associated with inhibition of cardiomyocyte prolifera-
tion. TBX5 inhibition of cell proliferation in vitro and in
vivo was abrogated by the Gly80Arg TBX5 missense muta-
tion at the 59 end of the TBX5 T-box but was not altered by
deletion of the 39 end of the T-box. Furthermore, we
observed that those cells not overexpressing TBX5 but that
were in the same in vitro or in vivo milieu as cells which
were overexpressing TBX5 exhibited similarly decreased
proliferation.
Diminished cell numbers during growth in tissue culture
can result from inhibition of cell proliferation or cell
survival. Our in vitro studies of D17s and MEQCs infected
with TBX5 retroviruses revealed no evidence of cell necro-
sis or apoptosis. Similarly, our histological and immunohis-
tochemical analyses of TBX5 transgenic chick hearts with
reduced size failed to show any evidence cardiomyocyte
necrosis or apoptosis. On the other hand, reduced fractions
of PCNA-positive cells in these hearts demonstrate a role
for TBX5 in inhibition of cardiomyocyte proliferation. Fur-
ther investigation of TBX5 antiproliferative activity in vivo
ill determine at what stage TBX5 blocks the cell cycle and
he intracellular mediators of this activity.
Other cellular processes and events could potentially
ontribute to defective organ growth and morphogenesis in
BX5 transgenic chick hearts. Our histologic analyses do
ot reveal any significant alterations in connective tissue
istribution or cardiomyocyte size in these animals. How-
ver, we cannot exclude subtle changes in extracellular
atrix composition or cell shape as contributors to the
ecreased heart size in TBX5 transgenic chick hearts. As
urther investigation establishes the downstream targets of
BX5 that mediate its antiproliferative activity, detailed
nalyses of extracellular matrix protein expression and
ardiomyocyte morphology may be informative.
Abnormal cardiac chamber specification can also alter
t-TBX5
(n 5 16)
Gly80Arg-TBX5
(n 5 6)
DASN198FSter-TBX5
(n 5 12)
.0 6 1.5a 73.5 6 4.4 58.3 6 3.0a
.11 6 0.01 1.12 6 0.01 1.13 6 0.03
.2 6 1.3a 64.7 6 3.3 52.0 6 2.6aTABLE 1
Effects of TBX5 Isoform Overexpression on Chick Heart Development
CXIZ Control
(n 5 13)
w
Heart weight (mg) 70.5 6 2.5 59
Tibia length (mm) 1.13 6 0.04 1
eart weight/tibia length (mg/mm) 62.3 6 2.0 53
Data are mean 6 SEM.FIG. 6. Atrial myosin heavy-chain expression in TBX5 transgenic
hick hearts. Embryonic chick hearts infected with CXIZ retrovi-
us encoding wild-type TBX5 were prepared for cryosectioning.
arallel sections were immunostained for atrial myosin heavy
hain with AMHC1 (a–d) or for rhTBX5 with affinity-purified
nti-TBX5 (e,f). AMHC1 staining is shown in (a) right atrium, (b)
eft atrium, (c) right ventricle, and (d) left ventricle. Parallel
entricular regions to those shown in c and d are shown in e and f
ith immunostaining for TBX5 which exhibits predominant
uclear localization. AMHC1 staining was restricted to the right (a)
nd left (b) atria and was absent from the right (c) and left (d)
entricles even in regions where rhTBX5 is expressed at high levelsrganogenesis. Just as we observed impaired ventricular
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185TBX5 Inhibits Proliferation during Cardiogenesisdevelopment with decreased trabeculation due to TBX5
overexpression in the chick, Liberatore et al. (2000) ob-
served that overexpression of Tbx5 in the murine ventricle
resulted in a failure of cardiogenesis. They observed thin-
walled ventricular chambers with reduced trabeculation
and hypothesized that these abnormalities might involve
aberrant chamber specification and atrialization of ventric-
ular myocardium. Immunohistochemical studies in our
chick model, though, demonstrate restriction of atrial myo-
sin heavy-chain expression to the atria even in the face of
TBX5 isoform overexpression. Thus, our model dissociates
cell proliferation from atrial specification. Such dissocia-
tion may be a consequence of the timing of TBX5 overex-
pression intrinsic to the two experimental designs. Al-
though TBX5 overexpression as driven by the b-myosin
heavy-chain promoter in the murine model should begin
early in development of the primitive heart tube at the 6–8
somite stage (Colbert et al., 1997), TBX5 overexpression in
ur model commences later, after stages 17–18 of chick
evelopment.
We, therefore, suggest that the same altered regulation of
ell proliferation that underlies the chick phenotype is
perant in the Tbx5 transgenic mouse and participates in
he murine cardiogenic defect. It is intriguing to note that
n mouse (Bruneau et al., 1999; Liberatore et al., 2000),
hick (Bruneau et al., 1999), and humans (Hatcher et al.,
000), TBX5 is expressed in an anterior–posterior gradient
uring embryogenesis that results in higher levels of atrial
FIG. 7. Effect of TBX5 overexpression on cardiomyocyte proliferat
encoding wild-type and mutant TBX5 isoforms, animals sacrificed
sections were immunostained with antibodies to b-galactosidase an
ositive cells (solid bars) as well as in b-galactosidase negative cells
isoform, more than 500 infected and uninfected cells were counted
earts is denoted (*).xpression than ventricular expression. Native TBX5- m
Copyright © 2001 by Academic Press. All rightnduced inhibition of cardiomyocyte proliferation may,
hen, contribute to the atria developing as thin-walled
tructures rather than thick-walled trabeculated chambers
uch as the ventricles.
Both in vitro and in vivo, we observed that nontransgenic
ells in the same culture dish or same heart as transgenic
BX5 overexpressing cells exhibited similar inhibition of
roliferation. Our observations that infection with the
XIZ retrovirus alone does not alter cell proliferation and
hat TBX5 antiproliferative activity on both cell popula-
ions is abolished by the Gly80Arg missense mutations
xclude a nonspecific cytotoxic effect of the constructs
sed. We, then, propose that TBX5-mediated inhibition of
ell proliferation must, at least, include a noncell autono-
ous component. Such a paracrine effect of TBX5 expres-
ion, potentially mediated by either soluble or extracellular
atrix bound factors, could contribute TBX5 modulation of
verall organ morphology even in the face of local varia-
ions in TBX5 expression. Ultimately, identification of
ardiac mediators of the TBX5-dependent paracrine signal-
ng that results in regional proliferative arrest will further
est this hypothesis.
Why might the Gly80Arg missense mutation of the 59
nd of the T-box diminish the capacity of TBX5 to inhibit
ell proliferation whereas deletion of the 39 end of the T-box
oes not? On one hand, deletions at either the 59 or 39 ends
f the Xenopus T(Brachyury) T-box alter DNA binding in
itro (Kispert and Herrmann, 1993; Kispert et al., 1995), and
n vivo. Embryonic chick hearts were infected with CXIZ retrovirus
5, and chick hearts prepared for histology as in Fig. 4. Five micron
NA. The percentages of PCNA positive nuclei in b-galactosidase-
uninfected trabeculae (open bars) were calculated. For each TBX5
six chick hearts. P , 0.0001 compared with CXIZ-infected controlion i
at E1
d PC
from
fromissense mutation of the TBX5 T-box at Gly80 and Arg237
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186 Hatcher et al.both impair T-box/DNA interactions in electromobility
shift assays (R. Lin, C. Seidman, J. Seidman, personal
communication). On the other hand, crystallographic ex-
periments with the Xenopus T(Brachyury) T-box (Mu¨ller
and Herrmann, 1997) have predicted that the 59 end of the
T-box, including the homologous residue to human TBX5
Gly80 (Basson et al., 1999), encodes a binding domain for
arget DNA major groove while the 39 end of the T-box
ncodes a binding domain for target DNA minor groove.
hus, based on this crystallographic model and our current
bservations, we hypothesize that TBX5 binding to target
NA major groove is necessary for TBX5-mediated regula-
ion of cell proliferation. However, inhibition of cell prolif-
ration may only be one of many TBX5 contributions to
mbryogenesis that could require one or both of these
utative binding sites.
Finally, we observe significant concordance between the
ransgenic chick cardiac phenotype and some aspects of the
uman Holt–Oram cardiac phenotype. Although septation
efects are most readily apparent in Holt–Oram patients by
oninvasive clinical technology, these defects develop
FIG. 8. Expression of TBX5 and a marker of cell proliferation (Ki-6
tissues from 10–15 weeks of gestation of human embryos were imm
of TBX5 (a, c, e, g, i) and Ki-67 (b, d, f, h, j). Reciprocal patterns o
representative sections of cardiac tissue from 13.5 (a,b) and 10 week
11 week embryo (i,j). High levels of TBX5 expression (a,c) were ob
well as the LA myocardium, while high levels of Ki-67 expression
the atrioventricular groove in each section.) Magnified views of the
In the distal phalanx of the thumb, high levels of TBX5 express
musculature (g) where high levels of Ki-67 expression (h) were o
expression (i) were observed only in the inner cell layer of the deve
of Ki-67 expression were observed (j). Dark coloring of the retinal p
tissue processing not immunostaining. (Magnification bars 5 10 mithin the broader context of cardiac isomerism defects
Copyright © 2001 by Academic Press. All rightith abnormal chamber morphogenesis including altered
yocardial trabeculation (Gall et al., 1966; Ruzic et al.,
981; Sahn et al., 1981; Hurst et al., 1991; OMIM, 1996;
Basson et al., 1999). In our chick studies as well as the Tbx5
transgenic mouse reported by Liberatore et al. (2000), TBX5
overexpression disrupts myocardial trabeculation. The
Gly80Arg missense mutation which blocks wild-type TBX5
antiproliferative activity in our studies is known to severely
compromise human cardiac development (Basson et al.,
1999). A hallmark of Holt–Oram syndrome in individuals
heterozygous for Gly80Arg-TBX5 is increased right ventric-
ular trabeculation (Gall et al., 1966; Basson et al., 1999). In
chick, the overexpression of the Gly80Arg TBX5 mutant
has no effect on cardiac development/trabeculation and
cardiomyocyte proliferation, and the inhibitory activity of
wild-type TBX5 overexpression is not observed. We hypoth-
esize that Holt–Oram patients who are heterozygous for the
Gly80Arg-TBX5 mutation may have genetically reduced
levels of active wild-type TBX5 which might fail to approxi-
mately inhibit cardiomyocyte proliferation during ventric-
ular development and thus result in the increased trabecu-
ring human embryogenesis. Heart (a–d), thumb (e–h), and eye (i,j)
histochemically analyzed in parallel tissue sections for expression
X5 and Ki-67 expression were noted in all tissues. Displayed are
) embryos, thumb from a 13.5 week embryo (e–h), and eye from an
d in the epicardium of the left atria (LA) and left ventricle (LV) as
ere observed only in the LV myocardium. (A dashed line denotes
atrium show similar patterns of TBX5 (c) and Ki-67 expression (d).
were observed only in the bone (e), but not in the surrounding
ed compared with the bone (f). In the eye, high levels of TBX5
g sensory retina, but not in the outer cell layer where high levels
nted epithelium (PE) represents native pigmentation preserved in7) du
uno
f TB
(c,d
serve
(b) w
right
ion
bserv
lopin
igmelation. Yang et al.’s (2000) recent identification of
s of reproduction in any form reserved.
187TBX5 Inhibits Proliferation during Cardiogenesisadditional TBX5 missense mutations at the 59 end of the
T-box that have cardiovascular consequences in Chinese
Holt–Oram patients similar to Gly80Arg-TBX5 will now
permit additional evaluation of the potential contribution
of this T-box domain to heart development.
The relevance of TBX5’s antiproliferative effects to devel-
opment of other organs besides the heart remains to be
determined. Several investigators (Rodriguez-Esteban et al.,
1999; Takeuchi et al., 1999; Koshiba-Takeuchi et al., 2000)
have used overexpression and misexpression of chick Tbx5
to study organogenesis. During limb outgrowth, chick Tbx5
may participate in a feedback loop with BMP, WNT, and
FGF isoforms that regulate proliferation (Rodriguez-Esteban
et al., 1999; Takeuchi et al., 1999). Tbx5 may also modify
proliferative responses in the developing chick eye where
misexpression of chick Tbx5 alters retinotectum axonal
projections (Koshiba-Takeuchi et al., 2000). Our survey of
available human embryonic tissue shows that TBX5 expres-
sion is inversely related to expression of nuclear proliferat-
ing antigens in the limb and eye as well as in the heart
during human embryogenesis. These observations are con-
sistent with a role for T-box transcription factor regulation
of proliferative responses during ontogeny of these other
organ systems. Identification of genes regulated by TBX5
will ultimately define molecular genetic pathways that
mediate paracrine regulation of cell proliferation during
vertebrate organogenesis.
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